Intech Investment Management LLC significantly reduced its stake in ExxonMobil Corporation (NYSE:XOM) by 62.0% during the fourth quarter, selling 342,745 shares. Despite this, other institutional investors like Franklin Resources Inc., Mercer Global Advisors Inc. ADV, and AQR Capital Management LLC increased their holdings in the oil and gas giant. ExxonMobil recently announced a quarterly dividend and its stock is rated "Hold" by analysts with a consensus target price of $165.55.

Intech Investment Management LLC significantly increased its stake in Motorola Solutions, Inc. (NYSE: MSI) by 76.3% in the fourth quarter, bringing its total holdings to 79,516 shares valued at $30.48 million. Several other institutional investors also increased their positions in MSI. The article also provides details on Motorola Solutions' financial performance, dividend announcement, analyst ratings, and insider activity.

Intech Investment Management LLC reduced its stake in American Express Company (AXP) by 13.5% in the fourth quarter, holding 79,534 shares valued at $29.42 million. Despite this, other institutional investors increased their positions, and American Express reported strong Q1 earnings, beating analyst estimates with revenue up 11.4% year-over-year. The company also increased its quarterly dividend and reaffirmed positive sentiment from analysts regarding its growth and spending model.

Intech Investment Management LLC reduced its stake in The Progressive Corporation (NYSE:PGR) by 51.6% in the fourth quarter, selling 197,581 shares. Despite this, other institutional investors like Vanguard Group Inc. and State Street Corp increased their holdings. Wall Street analysts maintain a "Hold" consensus rating for Progressive with an average target price of $238.11, while the company recently reported strong Q1 earnings and declared a quarterly dividend.

Intech Investment Management LLC significantly increased its stake in Bank Of Montreal (BMO) by 69.5% in the fourth quarter, now holding 233,814 shares valued at $30.41 million. Other institutional investors like Vanguard Group Inc. and Canerector Inc. also boosted their holdings. The bank recently reported strong Q2 2026 results with increased earnings and a dividend hike, leading to positive analyst sentiment, though some caution was noted regarding credit data.

Intech Investment Management LLC significantly increased its stake in EOG Resources, Inc. by 856.2% in the fourth quarter, now owning 300,434 shares valued at $31.55 million. Other institutional investors also raised their positions in the energy exploration company. Wall Street analysts have issued a "Moderate Buy" consensus rating for EOG Resources with an average price target of $156.39.

Intech Investment Management LLC significantly increased its stake in Sysco Corporation (NYSE:SYY) by 698.3% during the fourth quarter, now owning 435,774 shares valued at $32.11 million. Other institutional investors also adjusted their positions in Sysco, with hedge funds and institutional investors collectively owning 83.41% of the company's stock. Sysco recently announced an increased quarterly dividend of $0.55 per share and reported Q1 earnings that narrowly missed analyst estimates.

Intech Investment Management LLC increased its stake in Gilead Sciences (NASDAQ:GILD) by 19.9% in the fourth quarter, purchasing an additional 48,622 shares. This acquisition brings their total holdings to 293,214 shares valued at $35,989,000. Other institutional investors also adjusted their positions in the biopharmaceutical company, which has an average analyst rating of "Moderate Buy" and a price target of $156.93.

Intech Investment Management LLC significantly reduced its stake in General Motors (NYSE:GM) by 42.3% in the fourth quarter, selling 371,494 shares. Other institutional investors like Foundations Investment Advisors LLC and Baker Avenue Asset Management LP increased their holdings. Additionally, CEO Mary T. Barra and EVP Rory Harvey sold large amounts of GM stock, though these sales were part of pre-arranged trading plans.

Boston Scientific has made a significant $1.5 billion investment, signaling a major move into the heart valve market. This action indicates a direct challenge to Edwards Lifesciences, the current leader in this medical device sector. The article highlights Boston Scientific's strategic intent to compete for market share in the transcatheter aortic valve replacement (TAVR) space.